Chronic mountain sickness: Difference between revisions

(Created page with "==Diagnosis== #Excessive polycythemia for a given altitude (Hb >20 ##Occurs in pts living at high-altitude who have COPD, sleep apnea or impaired resp drive #Head ache, diff...")
 
 
(8 intermediate revisions by 5 users not shown)
Line 1: Line 1:
==Diagnosis==
==Background==
#Excessive polycythemia for a given altitude (Hb >20  
*Excessive [[polycythemia]] for a given altitude (Hgb >20)
##Occurs in pts living at high-altitude who have COPD, sleep apnea or impaired resp drive  
*Occurs in patients living at high-altitude who have [[COPD]], sleep apnea or impaired respiratory drive  
#Head ache, difficulty thinking, impaired peripheral circulation, drowsiness
 
==Treatment==
==Clinical Features==
#Phlebotomy  
*[[Headache]]
#Relocation to lower altitude  
*Difficulty thinking
#Home O2 use
*Impaired peripheral circulation
*[[fatigue|Drowsiness]]
 
==Differential Diagnosis==
{{High altitude DDX}}
 
==Evaluation==
{{Expected SpO2 at altitude}}
 
==Management==
*Phlebotomy  
*Relocation to lower altitude  
*Home [[O2]] use


==See Also==
==See Also==
[[High Altitude Medicine]]
*[[High Altitude Medicine]]


==Source==
==References==
Tintinalli
<references/>


[[Category:Environ]]
[[Category:Environmental]]

Latest revision as of 19:27, 2 March 2020

Background

  • Excessive polycythemia for a given altitude (Hgb >20)
  • Occurs in patients living at high-altitude who have COPD, sleep apnea or impaired respiratory drive

Clinical Features

Differential Diagnosis

High Altitude Illnesses

Evaluation

Expected SpO2 and PaO2 levels at altitude[1]

Altitude SpO2 PaO2 (mm Hg)
1,500 to 3,500 m (4,900 to 11,500 ft) about 90% 55-75
3,500 to 5,500 m (11,500 to 18,000 ft) 75-85% 40-60
5,500 to 8,850 m (18,000 to 29,000 ft) 58-75% 28-40

Management

  • Phlebotomy
  • Relocation to lower altitude
  • Home O2 use

See Also

References

  1. Gallagher, MD, Scott A.; Hackett, MD, Peter (August 28, 2018). "High altitude pulmonary edema". UpToDate. Retrieved May 2, 2019.